The addition of pertuzumab to the treatment regimen of docetaxel and trastuzumab increases a patient’s risk of: A. increased hepatocellular toxicities. B. decreased left ventricular ejection fraction. C. decreased renal function and clearance. D. increased central and peripheral neuropathies.
[Verified Answer]: The addition of pertuzumab to the treatment…
Need help with your Renal, Fluid & Electrolytes case study or NCLEX preparation? Connect with a verified Nursing expert now.